dihexa cancer risk hgf c-met targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the receptor, it helps cells take in nutrients and rebuild—especially in cases where recovery is HGF/MET Signaling in Malignant Brain
HGF MET Signaling in Malignant Brain Tumors HGF and MET: From Brain Development to Neurological Disorders PMC dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



